Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Denton

Showing results (221-230 of 607) with videos related to

Pageof 61
Sort By:
Arthritis and Rheumatism|August 29, 2009
Loss of peroxisome proliferator-activated receptor gamma in mouse fibroblasts results in increased susceptibility to bleomycin-induced skin fibrosisMohit Kapoor, Matthew McCann, Shangxi Liu, et al.
American Journal of Respiratory and Critical Care Medicine|December 17, 2019
Etiology, Risk Factors, and Biomarkers in Systemic Sclerosis with Interstitial Lung DiseaseDinesh Khanna, Donald P Tashkin, Christopher P Denton, et al.
Clinical and Experimental Rheumatology|August 6, 2013
Functional impairment of systemic scleroderma patients with digital ulcerations: results from the DUO RegistryLoïc Guillevin, Elke Hunsche, Christopher P Denton, et al.
Journal of Scleroderma and Related Disorders|July 5, 2021
Clinical trial protocol: PRednisolone in early diffuse cutaneous Systemic Sclerosis (PRedSS)Ariane L Herrick, Deborah J Griffiths-Jones, W David Ryder, et al.
Nature Reviews. Rheumatology|February 27, 2023
State-of-the-art evidence in the treatment of systemic sclerosisJanet E Pope, Christopher P Denton, Sindhu R Johnson, et al.
Annals of the Rheumatic Diseases|November 28, 2015
Elucidating the burden of recurrent and chronic digital ulcers in systemic sclerosis: long-term results from the DUO RegistryMarco Matucci-Cerinic, Thomas Krieg, Loic Guillevin, et al.
Stem Cell Research & Therapy|February 9, 2017
Characteristics of human adipose derived stem cells in scleroderma in comparison to sex and age matched normal controls: implications for regenerative medicineMichelle Griffin, Caroline M Ryan, Omar Pathan, et al.
Clinical Rheumatology|September 5, 2019
Optimisation of botulinum toxin type a treatment for the management of Raynaud's phenomenon using a dorsal approach: a prospective case seriesKiran Dhaliwal, Michelle F Griffin, Sebastian Salinas, et al.
Rheumatology (Oxford, England)|August 24, 2020
High proton pump inhibitor exposure increases risk of calcinosis in systemic sclerosisLauren V Host, Corrado Campochiaro, Ana Afonso, et al.
Rheumatology (Oxford, England)|May 6, 2003
A cross-sectional comparison of three self-reported functional indices in sclerodermaA E Smyth, A J MacGregor, D Mukerjee, et al.
Pageof 61

Showing results (221-230 of 607) with videos related to

Sort By:
Pageof 61
Arthritis and Rheumatism|August 29, 2009
Loss of peroxisome proliferator-activated receptor gamma in mouse fibroblasts results in increased susceptibility to bleomycin-induced skin fibrosisMohit Kapoor, Matthew McCann, Shangxi Liu, et al.
American Journal of Respiratory and Critical Care Medicine|December 17, 2019
Etiology, Risk Factors, and Biomarkers in Systemic Sclerosis with Interstitial Lung DiseaseDinesh Khanna, Donald P Tashkin, Christopher P Denton, et al.
Clinical and Experimental Rheumatology|August 6, 2013
Functional impairment of systemic scleroderma patients with digital ulcerations: results from the DUO RegistryLoïc Guillevin, Elke Hunsche, Christopher P Denton, et al.
Journal of Scleroderma and Related Disorders|July 5, 2021
Clinical trial protocol: PRednisolone in early diffuse cutaneous Systemic Sclerosis (PRedSS)Ariane L Herrick, Deborah J Griffiths-Jones, W David Ryder, et al.
Nature Reviews. Rheumatology|February 27, 2023
State-of-the-art evidence in the treatment of systemic sclerosisJanet E Pope, Christopher P Denton, Sindhu R Johnson, et al.
Annals of the Rheumatic Diseases|November 28, 2015
Elucidating the burden of recurrent and chronic digital ulcers in systemic sclerosis: long-term results from the DUO RegistryMarco Matucci-Cerinic, Thomas Krieg, Loic Guillevin, et al.
Stem Cell Research & Therapy|February 9, 2017
Characteristics of human adipose derived stem cells in scleroderma in comparison to sex and age matched normal controls: implications for regenerative medicineMichelle Griffin, Caroline M Ryan, Omar Pathan, et al.
Clinical Rheumatology|September 5, 2019
Optimisation of botulinum toxin type a treatment for the management of Raynaud's phenomenon using a dorsal approach: a prospective case seriesKiran Dhaliwal, Michelle F Griffin, Sebastian Salinas, et al.
Rheumatology (Oxford, England)|August 24, 2020
High proton pump inhibitor exposure increases risk of calcinosis in systemic sclerosisLauren V Host, Corrado Campochiaro, Ana Afonso, et al.
Rheumatology (Oxford, England)|May 6, 2003
A cross-sectional comparison of three self-reported functional indices in sclerodermaA E Smyth, A J MacGregor, D Mukerjee, et al.
Pageof 61